Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Avanir
Pharma
Eisai, GSK, Daiichi Sankyo—Fierce Pharma Asia
Eisia's lecanemab phase 3 had one patient death. China suspends GSK from volume-based procurement. Daiichi increases its Enhertu sales projection.
Angus Liu
Nov 4, 2022 9:00am
Astellas, Takeda, Lilly-Innovent and more—FiercePharmaAsia
Jan 17, 2020 8:40am
Otsuka's Avanir unit plots 140 layoffs after Nuedexta settlement
Jan 10, 2020 11:35am
Otsuka, China's bidding, Aurobindo and more—FiercePharmaAsia
Sep 27, 2019 10:10am
Avanir agrees to pay $116M over Nuedexta kickbacks probe
Sep 26, 2019 3:55pm
Feds put Acadia's Nuplazid marketing under the microscope
Mar 11, 2019 11:12am